Oldenburg HSA - Search Results

1

Breast conserving surgery for extensive DCIS using multiple radioactive seeds.

Janssen NNY, van la Parra RFD, Loo CE, Groen EJ, van den Berg MJ, Oldenburg HSA, Nijkamp J, Vrancken Peeters MTFD. Janssen NNY, et al. Among authors: oldenburg hsa. Eur J Surg Oncol. 2018 Jan;44(1):67-73. doi: 10.1016/j.ejso.2017.11.002. Epub 2017 Nov 20. Eur J Surg Oncol. 2018. PMID: 29239733

2

Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.

Meijnen P, Peterse JL, Oldenburg HS, Woerdeman LA, Rutgers EJ. Meijnen P, et al. Eur J Surg Oncol. 2005 Oct;31(8):833-9. doi: 10.1016/j.ejso.2005.03.016. Eur J Surg Oncol. 2005. PMID: 15923104

3

Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.

van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, Kroon BB. van Rijk MC, et al. Ann Surg Oncol. 2006 Apr;13(4):475-9. doi: 10.1245/ASO.2006.07.025. Epub 2006 Feb 17. Ann Surg Oncol. 2006. PMID: 16485148

4

Sentinel node biopsy and concomitant probe-guided tumor excision of nonpalpable breast cancer.

van Rijk MC, Tanis PJ, Nieweg OE, Loo CE, Olmos RA, Oldenburg HS, Rutgers EJ, Hoefnagel CA, Kroon BB. van Rijk MC, et al. Ann Surg Oncol. 2007 Feb;14(2):627-32. doi: 10.1245/s10434-006-9070-4. Epub 2006 Dec 6. Ann Surg Oncol. 2007. PMID: 17151797

5

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.

Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ. Meijnen P, et al. Br J Surg. 2007 Aug;94(8):952-6. doi: 10.1002/bjs.5735. Br J Surg. 2007. PMID: 17440955

6

Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.

Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ. Meijnen P, et al. Ann Surg Oncol. 2008 Jan;15(1):235-43. doi: 10.1245/s10434-007-9659-2. Epub 2007 Nov 7. Ann Surg Oncol. 2008. PMID: 17987342

7

[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].

Straver ME, van Adrichem JC, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Gilhuijs KG, Oldenburg HS, Wesseling J, Russell NS, Antonini N, Vrancken Peeters MT. Straver ME, et al. Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2519-25. Ned Tijdschr Geneeskd. 2008. PMID: 19055260 Dutch.

8

Lymphatic drainage patterns in breast cancer patients who previously underwent mantle field radiation.

van der Ploeg IM, Russell NS, Nieweg OE, Oldenburg HS, Kroon BB, Olmos RA, Rutgers EJ. van der Ploeg IM, et al. Ann Surg Oncol. 2009 Aug;16(8):2295-9. doi: 10.1245/s10434-009-0506-5. Epub 2009 May 19. Ann Surg Oncol. 2009. PMID: 19452228

9

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

Aukema TS, Rutgers EJ, Vogel WV, Teertstra HJ, Oldenburg HS, Vrancken Peeters MT, Wesseling J, Russell NS, Valdés Olmos RA. Aukema TS, et al. Eur J Surg Oncol. 2010 Apr;36(4):387-92. doi: 10.1016/j.ejso.2009.11.009. Epub 2009 Dec 3. Eur J Surg Oncol. 2010. PMID: 19962268

10

MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.

Straver ME, Loo CE, Rutgers EJ, Oldenburg HS, Wesseling J, Vrancken Peeters MJ, Gilhuijs KG. Straver ME, et al. Ann Surg. 2010 Apr;251(4):701-7. doi: 10.1097/SLA.0b013e3181c5dda3. Ann Surg. 2010. PMID: 20224378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters